Product Analytics
#360 | Quantifying Sequence of Return Risk with LISA
Full Article Risk is a fiendishly difficult thing to quantify. In financial theory, risk is usually quantified in terms of standard deviation – the greater the variance, the greater the risk. Famously, Nassim Taleb popularized the idea of “black swan”…
#359 | The New Weapons of AG 49-B
This article assumes a base level of knowledge about Indexed UL illustrations, the previous forms of AG 49, the impact of using engineered indices with fixed interest bonuses and the basic mechanics of the recent revisions to AG 49-A, colloquially…
#352 | The Walls are Closing In on Term Conversions
Editorial Note - I am increasingly receiving article submissions from readers and other parties. My role has always been as Executive Editor, which ostensibly means that I'm serving as an editor of this publication, not just an author. It's my…
#349 | A Reckoning in Term
2/10/23 Update On Lincoln's Q4 2022 earnings call yesterday, analysts peppered CEO Ellen Cooper and CFO Randy Freitag about Lincoln's position on Term, given that reserving for it has "negatively impacted free cash flow," as one analyst put it. The…
#339 | The New Breed of Protection-Oriented IUL
Quick Take Historically, there was a clear distinction between protection-oriented and accumulation-oriented Universal Life products. The latter tended to have higher liquidity but also higher long-term policy charges, particularly COIs, whereas the former tended to have lower liquidity but also…
#334 | Whole Life Through the Lens of a UL Believer
For the past 3 weeks, I’ve been doing a weekly webinar for AIN* that Jeff Reed, AIN’s maestro of content, entitled “Whole Life Through the Lens of a UL Believer.” The title is a nod to the path of my…
#330 | IUL Cap Divergence
This article is protected by copyright and the terms of this website. If you share it with non-subscribers without written permission from The Life Product Review, you will lose your subscription without a refund and will receive an invoice for…
#328 | Rising Rates and Section 7702
This article is protected by copyright and the terms of this website. If you share it with non-subscribers without written permission from The Life Product Review, you will lose your subscription without a refund and will receive an invoice for…
#324 | The True Cost of Engineered Indices
Quick Take For all of their real, purported and back-tested benefits, engineered indices come at a cost in the form of fees that aren't charged on standard indices such as the S&P 500. These fees generally take three forms -…
#322 | Crossover
Earlier this morning, I sent out an email to all past and present subscribers to The Life Product Review asking for candid feedback on the site and how it can improve. The responses so far have been incredibly helpful -…
